{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=53", "query": { "intervention": "Biological Control", "page": 53 }, "page_size": 10 }, "pagination": { "page": 53, "page_size": 10, "total_count": 1573, "total_pages": 158, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=54&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=52&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-01T19:26:41.598Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07002060", "title": "Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Yellow Fever Immunization" ], "interventions": [ { "name": "Yellow fever vaccine (live)", "type": "BIOLOGICAL" }, { "name": "YF vaccine (live)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 640, "start_date": "2025-05-22", "completion_date": "2026-01-20", "has_results": false, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 7, "location_summary": "Decatur, Georgia • New Orleans, Louisiana • Baltimore, Maryland + 4 more", "locations": [ { "city": "Decatur", "state": "Georgia" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07002060" }, { "nct_id": "NCT04237623", "title": "GM-CSF With Post-Transplant Cyclophosphamide", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Transplant-Related Hematologic Malignancy" ], "interventions": [ { "name": "Sargramostim", "type": "DRUG" }, { "name": "Control Arm", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Northside Hospital, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "18 Years to 78 Years" }, "enrollment_count": 38, "start_date": "2020-05-18", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04237623" }, { "nct_id": "NCT01248520", "title": "Influenza and Text Messaging in Pregnancy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pregnancy" ], "interventions": [ { "name": "influenza and general health information", "type": "OTHER" }, { "name": "general health information", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "14 Years to 50 Years · Female only" }, "enrollment_count": 216, "start_date": "2010-09", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2018-12-13", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01248520" }, { "nct_id": "NCT00006734", "title": "Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "adjuvant therapy", "type": "PROCEDURE" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "neoadjuvant therapy", "type": "PROCEDURE" }, { "name": "brachytherapy", "type": "RADIATION" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "0 Years to 50 Years" }, "enrollment_count": 587, "start_date": "2001-05", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-08-03", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 212, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 155 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006734" }, { "nct_id": "NCT00122681", "title": "Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Papillomavirus" ], "interventions": [ { "name": "Cervarix™", "type": "BIOLOGICAL" }, { "name": "Havrix™-based investigational formulation", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "25 Years", "sex": "FEMALE", "summary": "15 Years to 25 Years · Female only" }, "enrollment_count": 18729, "start_date": "2004-05-06", "completion_date": "2009-11-26", "has_results": true, "last_update_posted_date": "2018-08-20", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Fountain Valley, California • San Diego, California + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fountain Valley", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00122681" }, { "nct_id": "NCT00832364", "title": "Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Acitretin (also called U0279)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Etanercept", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2009-10", "completion_date": "2010-04", "has_results": false, "last_update_posted_date": "2015-04-21", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 3, "location_summary": "San Francisco, California • Louisville, Kentucky • New York, New York", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00832364" }, { "nct_id": "NCT00192309", "title": "Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "CAIV-T", "type": "BIOLOGICAL" }, { "name": "TIV", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 31, "start_date": "2001-09", "completion_date": "2001-12", "has_results": false, "last_update_posted_date": "2012-02-14", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 1, "location_summary": "Stamford, Connecticut", "locations": [ { "city": "Stamford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00192309" }, { "nct_id": "NCT02165111", "title": "Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Scleroderma", "Raynaud's Syndrome" ], "interventions": [ { "name": "Onabotulinumtoxin A", "type": "DRUG" }, { "name": "sterile saline solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2015-01", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2016-12-22", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02165111" }, { "nct_id": "NCT00299546", "title": "A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Golimumab 50 mg", "type": "BIOLOGICAL" }, { "name": "Golimumab 100 mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 461, "start_date": "2006-02", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2014-02-27", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Paradise Valley, Arizona + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00299546" }, { "nct_id": "NCT01147497", "title": "Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "Misoprostol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 78, "start_date": "2010-06", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2018-01-12", "last_synced_at": "2026-11-01T19:26:41.598Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147497" } ] }